What you said I think might be a little wishful thinking. You're right in that we are expecting many other decisions soon (not just this one). But lets be cold hard and factual ok?
This Ryoncil approval is supposed to be our easy Steven Bradbury cruise through ANN. THIS is the one that is considered the easy win. If we are not approved for Ryoncil on what planet would we be approved for the same cells on more complex and less likely to be approved treatments especially adding in a 9-1 ODAC vote.
Make no mistake this ANN is the only one that counts. If the FDA can't support us here they won't support us anywhere else.
Ann: Trading Halt, page-183
-
- There are more pages in this discussion • 453 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.015(1.04%) |
Mkt cap ! $1.661B | |||
| Open | High | Low | Value | Volume |
| $1.44 | $1.46 | $1.40 | $3.815M | 2.664M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11031 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 14844 | 2 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |